Table 2.
Study | n | Follow-up(mo) |
Patients free of AF |
No. of ablation procedures | Major complications(ablation arm) (%) | Type of AF | ||
Ablation strategy (%) | AAD strategy (%) | P | ||||||
Wazni et al[48] (2005) | 70 | 12 | 88 | 37 | < 0.001 | 1 | 6.3 | Paroxysmal persistent |
Oral et al[50] (2006) | 146 | 12 | 74 | 58 | 0.05 | 1.4 | 0 | Permanent |
Stabile et al[49] (2006) | 137 | 12 | 56 | 9 | < 0.001 | 1 | 4.4 | Paroxysmal persistent |
Pappone et al[51] (2006) | 198 | 12 | 86 | 22 | < 0.001 | 1 | 2.0 | Paroxysmal |
Jaïs et al[52] (2008) | 112 | 12 | 88 | 24 | < 0.001 | 1.8 | 1.9 | Paroxysmal |
Forleo et al[53] (2009) | 70 | 12 | 80 | 57 | 0.001 | 1 | 2.9 | Paroxysmal persistent |
All studies demonstrated the superiority of catheter ablation over anti-arrhythmic drugs in AF patients with regard to maintenance of sinus rhythm. AF: Atrial fibrillation; AAD: Anti-arrhythmic drug.